Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Batch Reconciliation in MDI Production

Posted on By

SOP for Batch Reconciliation in MDI Production

Batch Reconciliation Procedures in MDI Production

1) Purpose

The purpose of this SOP is to establish procedures for batch reconciliation in metered-dose inhaler (MDI) production to ensure accurate accounting of materials, components, and documentation throughout the manufacturing process.

2) Scope

This SOP applies to all personnel involved in batch reconciliation activities within the MDI production facility, including production supervisors, inventory managers, and quality control technicians.

3) Responsibilities

The responsibilities for this SOP include reconciling batch records, verifying material usage, identifying discrepancies, and ensuring compliance with SOPs. Specific roles include:
Production Supervisors: Oversee batch reconciliation processes and review reconciliation reports.
Inventory Managers: Monitor material inventory levels and reconcile usage against production records.
Quality Control Technicians: Verify batch reconciliation accuracy and document any deviations observed.

See also  SOP for Stability Testing of MDIs

4) Procedure

4.1 Batch Record Review
4.1.1 Retrieve batch records and compare with initial production plans and BMRs.
4.1.2 Verify completeness and accuracy of recorded data, including material quantities and batch numbers.
4.2 Material Usage Verification
4.2.1 Assess material consumption against expected usage rates and reconcile discrepancies.
4.2.2 Document any variances or discrepancies identified during material reconciliation.
4.3 Documentation and Reporting

4.3.1 Prepare batch reconciliation reports detailing findings and corrective actions taken.
4.3.2 Obtain approvals from designated personnel (e.g., quality assurance) before finalizing batch reconciliation.

5) Abbreviations, if any

MDI: Metered-Dose Inhaler
SOP: Standard Operating Procedure
BMR: Batch Manufacturing Record

See also  SOP for Color Consistency Testing in MDIs

6) Documents, if any

Batch reconciliation templates, reconciliation reports, batch records, and approval documents should be maintained.

7) Reference, if any

Refer to regulatory guidelines from agencies such as the FDA, EMA, and ICH for batch reconciliation requirements in pharmaceutical manufacturing.

8) SOP Version

Version 1.0

Metered-Dose Inhaler Tags:Analytical Method Development MDIs, Batch Manufacturing Record MDI, Calibration MDI Equipment, Cleaning Equipment MDIs, Color Consistency Testing MDI, Contamination Prevention MDI, Documentation MDI Manufacturing, Final Product Inspection MDI, Formulation Development MDI, In-process Testing Inhalers, Inhaler Manufacturing Procedures, Inhaler Quality Control SOP, Labeling MDI SOP, MDI Production SOPs, MDI Storage Conditions, Metered-Dose Inhaler SOP, Microbial Testing Inhalers, Packaging of MDIs Procedure, Particle Size Analysis MDIs, Preservative Efficacy MDIs, Process Optimization MDIs, Process Validation MDIs, Propellant Testing MDIs, Quality Testing MDIs, Raw Material Inspection MDIs, Solvents Use in MDI Production, Stability Testing MDIs, Sterility Maintenance MDI, Training Personnel MDI Production, Waste Disposal MDI Production

Post navigation

Previous Post: SOP for Aseptic Processing Area
Next Post: SOP for Assay of Active Ingredient in Powders

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version